CVE:CRM - CRH Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseC$121.40
Today's RangeC$118.81 - C$121.94
52-Week RangeC$83.00 - C$128.87
Volume1.67 million shs
Average Volume5.83 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.

Receive CRM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A

CRH Medical (CVE:CRM) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CRM."

Has CRH Medical been receiving favorable news coverage?

News stories about CRM stock have trended somewhat negative this week, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CRH Medical earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days.

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include Autodesk (ADSK), Cronos Group (CRON), Cisco Systems (CSCO), Lam Research (LRCX), LYFT (LYFT), Aurora Cannabis (ACB), Canopy Growth (CGC), Square (SQ), Constellation Brands (STZ) and Emerald Health Therapeutics (EMHTF).

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
  • Edward J. Wright, Chief Executive Officer, Director
  • Richard K. Bear, Chief Financial Officer (Age 48)
  • Jay Kreger, President of CRH Anesthesia Management
  • David Johnson, Independent Director
  • Bergein F. Overholt M.D., Independent Director
  • Todd R. Patrick, Independent Director (Age 48)
  • Ian A. Webb, Independent Director (Age 61)

How do I buy shares of CRH Medical?

Shares of CRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CRH Medical's official website?

The official website for CRH Medical is

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.

MarketBeat Community Rating for CRH Medical (CVE CRM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  230
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/21/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel